miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFβR3
Vida Chitsazzadeh(The University of Texas MD Anderson Cancer Center), Kenneth Y. Tsai(Moffitt Cancer Center)
Cited by 9
Related Papers
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
|The Lancet Oncology|2014|263
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates
|Nature Communications|2016|159
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
|Science Translational Medicine|2018|132